Boosting Immunity by Targeting Post-translational Prenylation of Small GTPases
Author(s) -
Caroline Robert,
Stéphan Vagner
Publication year - 2018
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2018.10.032
Subject(s) - biology , prenylation , boosting (machine learning) , gtpase , immunity , computational biology , small gtpase , microbiology and biotechnology , virology , immune system , signal transduction , genetics , biochemistry , artificial intelligence , enzyme , computer science
Diseases leading to immune activation and autoinflammatory phenotypes may provide a reservoir of potentially druggable pathways for optimizing immune adjuvants or boosting antitumor immune responses. Now, Xia et al. report that lipophilic statins or biphosphonates, targeting the mevalonate pathway, act as efficient vaccine adjuvants and synergize with anti-PD1 against cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom